Of these, PTPRK-RSPO3 and TPM3-NTRK1 are CRC-associated recurrent fusions that are amenable to the porcupine inhibitor and kinase inhibitor interventions, respectively73,77. This evidence concerns the gene NTRK1 and colorectal carcinoma.